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Abstract 
Introduction: Biochemical markers play an important role in the growth and repair of bone and 
can be evaluated in different biological fluids. Therefore, the aim of this study was to evaluate the 
level of insulin-like growth factor-I (IGF-I) in urine as a puberty index and to compare it with 
cervical vertebral maturational stages (CVMSs) in lateral cephalometry. 
Materials&Methods: In this cross-sectional study, 50 8-18-year-old patients (males and females), 
referred to Faculty of Dentistry with CVMS of 2 to 6 and needed orthodontic treatment as well as 
lateral cephalometry were selected. All of these patients were healthy. The CVMSs were recorded 
based on lateral cephalometric radiographs and urinary levels of IGF-I was determined using a 
urine-based ELISA kit. Mean IGF-I values for each CVMS were analyzed by Mann-Whitney, 
Kruskal-Wallis and Chi-square tests in SPSS. P<0.05 was statistically considered as significant level. 
Results: In this study, the mean age of participants, ranged from 8 to 18 years was 12.96±3.82. 
There was no statistically significant difference in gender distribution between CVM groups 
(P=0.106). The level of urinary IGF-I had no significant difference between groups, except for 
CVMS3 group (P=0.073). In CS3, the mean urinary IGF-I level was 0.2727, representing a 
significant difference from other groups (P=0.000). IGF-I levels had no significant differences 
between males (0.030.04) and females (0.080.011), (P=0.492). 
Conclusion: The highest urinary IGF-I level was found in both genders in CVMS 3 and 4, which 
coincided with peak growth spurt in patients. 
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 چکیدٌ
تَاى آًْا را بصَرت کوی در هارکزّای بیَؽیویایی اس جولِ عَاهلی ّغتٌذ کِ در رؽذ ٍ تزهین اعتخَاى ًقؼ دارًذ ٍ هی :مقدمٍ
در ادرار بعٌَاى  (FGI-I )1هایعات بیَلَصیکی ارسیابی کزد. ّذف اس ایي هطالعِ، ارسیابی تغییزات عطح فاکتَر رؽذ ؽبِ اًغَلیٌی 
 .در عفالَهتزی طزفی اعت )sSMVCّای گزدًی (یک ؽاخص بلَغ ٍ هقایغِ آى با هزاحل بلَغ هْزُ
عال در  8-81ی بیي عٌیي دًذاًپشؽک داًؾکذُ بِ کٌٌذُ بیوار (دختز ٍ پغز) هزاجعِ 05در ایي هطالعِ هقطعی  :َب مًاد ي ريش
ی گزدًی کِ ًیاس بِ درهاى ارتَدًغی ٍ رادیَگزافی لتزال عالَهتزی داؽتٌذ، اّ تکاهل هْزُ 6SMVCتا   2SMVCهحذٍدُ 
  بِ رٍػ  FGI-Iّای طزفی ٍ عطَح ادراری  بز أعاط عفالَهتزی sSMVCاًتخاب ؽذًذ. ایي افزاد ّوگی عالن بَدًذ. 
ی هي ّا ، با تغتSMVCط بزای ّز گزٍُ بز أعا  FGI-Iّای ادراری ثبت ؽذًذ. هقادیز هتَعط  با اعتفادُ اس کیتASILE
 .در ًظز گزفتِ ؽذ 50.0<Pداری  آًالیش ؽذًذ .عطح هعٌی  SSPSٍیتٌی، کزٍعکال ٍالیظ ٍ کای دٍ در ًزم افشار آهاری 
 تَسیع در داریهعٌی تفاٍت. بَد عال 81 تا 8 هحذٍدُ با 21/69 ±3/28 کٌٌذُؽزکت افزاد عٌی هیاًگیي هطالعِ ایي در :یبفتٍ َب
 غیز بِ ،SMVC هختلف ّایگزٍُ در FGI-I  ادراری طحع). 601.0=P( ًذاؽت ٍجَد MVC هختلف ّایزٍُگ در جٌغیتی
 عایز با کِ بَدُ0/7272 ،FGI-I ادراری عطح هیاًگیي ،3SC گزٍُ در0=P(..)370 ًذاؽتٌذ داریهعٌی تفاٍت ،3SC گزٍُ اس
 داری هعٌی تفاٍت)  0/300/40( سًاى ٍ) 0/800/110( داىهز بیي  FGI-I هقذار ).000.0=P( داؽت داریهعٌا تٍتفا ّاگزٍُ
 ).P-294.0=eulaV( ًذاؽت
گشارػ ؽذ  MVCهزحلِ عَم ٍ چْارم  در هذکز ٍ هًَث افزاد در ادراری  FGI-I حعط در ایي هطالعِ بالاتزیي :وتیجٍ گیری
 باؽذ.کِ هصادف با حذاکثز عزعت رؽذی در بیواراى هی
 ، هْزُ ّای گزدًی، تعییي عي اعکلتی1ذ ؽبِ اًغَلیٌی فاکتَر رؽ ياژگبن کلیدی:
 
 noitcudortnI
 ni noitarutam lateleks fo noitanimreted ehT
 ehT .ecnatropmi taerg fo si yrtsitned dna enicidem
 yb decneulfni ylgnorts si noitarutam lateleks fo gnimit
 .srotcaf latnemnorivne dna citeneg sa llew sa redneg
 lateleks etamitse ot desu neeb evah secidni tnereffiD
 latned ,ega lacigolonorhc ,thgieh gnidulcni noitarutam
 dna sdnah dna stsirw eht fo noitacificlac ,ega
.earbetrev lacivrec eht fo tnempoleved
]1[
 ynaM 
 a ton si ega lacigolonorhc taht nwohs evah srehcraeser
  ot eud ytrebup fo etats eht etaulave ot rotacidni elbailer
 
 gnoma noitarutam eht ni secnereffid tnacifingis eht
 si ti ,erofereht ;ega lacigolonorhc emas eht htiw elpoep
 lateleks gnitaulave rof rotacidni etairporppa na ton
 .noitarutam
]2[
 roop etacidni thgieh dna ega latneD 
 .trups htworg latrebup fo noitciderp eht ni htgnerts
]3[
 
 ti ,yrtemolahpec laretal dna shpargoidar tsirw hguorhT
 .ytrebup fo etats eht etaulave ot elbissop si
]4[
 
 erusne ot ro noitaidar evissecxe tneverp ot ,elihwnaeM
-nilusni yraniru sa hcus setutitsbus evitanretla ,stluser
 esongaid ot detseggus era )I-FGI( I-rotcaf htworg ekil
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the skeletal maturation. 
[5]
 Having background 
information about the craniofacial growth and 
development is essential for any orthodontist. Of course, 
this will be possible only via understanding the normal 
growth pattern and its underlying mechanisms. 
[6]
 
Dentofacial abnormalities in growing children are 
common causes for referring patients to orthodontists. 
These patients require functional or orthopedic 
treatments during growth or orthognathic surgery after 
peak pubertal growth. 
[7]
  
The golden time of treatment varies in different 
types of abnormalities; thus determining the treatment 
time is a substantial part to design the therapeutic 
approach. The issue of choosing the right time for 
orthopedic treatments is closely correlated with the 
timing of growth acceleration; hence, the developmental 
stage of each person, rate of skeletal maturity and 
remaining time for growth should be delineated. 
[8]
 A 
study has indicated that the greatest response to 
orthopedic treatment of mandible is obtained during 
puberty. In the case of mandible, the best results of 
orthopedic therapies are gained when treatment is 
performed in conjunction with increasing pubertal 
development. 
[9]
 The prediction of mandibular growth 
provides important information for the treatment plan 
and evaluation of the pre-treatment occlusion. 
[10]
 
Therefore, determining the stage of skeletal maturation 
and amount of residual growth before orthodontic 
treatment planning is considered to be important. 
[11]
  
Various indices including height, chronological age, 
dental age, calcification of wrist bones and cervical 
vertebral maturational stages (CVMS)s have been 
studied to estimate skeletal age. Owing to significant 
differences in puberty timing between individuals of the 
same age, chronological age is not a reliable indicator to 
assess the puberty and skeletal age. Dental age and 
height are also very poor in predicting pubertal growth 
spurt time. Skeletal age can be assessed by lateral 
cephalometric radiographs of the wrist and neck. 
[12]
 
Alternative tests like urinary IGF-I have been 
recommended to determine skeletal age in order to 
prevent excessive radiation or ensure results. In recent 
years, studies about IGF-I have represented the 
association of IGF-I levels with different stages of 
cervical vertebral maturational stages. 
[12,13]
 Most 
studies have been conducted on serum and fewer studies 
on saliva and urine samples. 
[14]
 Since the target 
population for predicting the skeletal age are children 
and adolescents, using a minimally invasive approach 
can be helpful in maximizing patient collaboration. 
Urinary IGF-I measurement has the least invasion and 
can be a suitable method to evaluate growth. 
[15]
  
Ryan et al. measured the amount of human salivary 
IGF-1, in which a low level of IGF-1 was found.  
Collecting salivary IGF-I is hard and there is a potential 
for contamination with saliva and blood fluid. 
Collecting and storing urine than saliva samples are 
relatively easier because the former is not technique-
sensitive. 
[16] 
Furthermore, no laboratory kits was found 
in the current study specifically to measure salivary 
IGF-I. The kits generally were for body fluids with no 
specific instruction for saliva. However, precise 
instructions were explained for testing urine samples. 
Therefore, the aim of this study was to assess the level 
of urinary IGF-I as a puberty index and to compare it 
with cervical vertebral maturational stages on lateral 
cephalometry. 
 
 
Materials & Methods 
This study was approved by the Ethics Committee of 
Babol University of Medical Sciences, Babol, Iran (with 
the code of MUBABOL.REC.1396.62). Totally, 50 8-
18-year-old patients, referred to Faculty of Dentistry 
were randomly selected for the present study. They 
needed orthodontic treatment and lateral cephalometric 
radiography. Inclusion criteria were no presence of 
systemic, congenital and hereditary diseases and growth 
disorders as well as no history of maxillofacial 
fractures. For data collection, The CVMS was recorded 
by observing lateral cephalometric radiographs 
[17]
 and 
the urinary IGF-I levels were evaluated using ELISA 
kit. 
Lateral cephalometric radiographs were prepared in 
the same center by Cranex D X-ray unit 
(Soredex, Finland). The CVMSs were evaluated by 2 
orthodontists independently so that both experts were 
unaware of patients’ age,growth status and IGF-I level. 
Evaluation of CVMSs was performed based on Graber 
et al. 
[17]
 Given that each specialist reads each 
cephalometric radiograph only once, a random error of 
up to 5% was considered. If the two orthodontists 
disagreed on some cases, they would reobserve the 
lateral cephalometries together to agree on a mutual 
conclusion. Approximately, the equal number of 
patients for all CVMSs (stages 2-6) was entered into the 
present study, and the patients were divided into 5 
groups.  
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The next morning of taking radiographs, the patients 
were referred to the Razi Laboratory for morning urine 
sampling. For evaluation of IGF-I, ELISA kit (Sigma 
Aldrich, Germany) was used and the results were 
reported as numerical values between 0-100 ng/ml. The 
sensitivity of this test was 0.05 ng/ml. Each kit 
contained 96 tests of which 10 ones were considered as 
standard. Urine samples were immediately extracted 
and stored according to the company's instructions, at -
20° C. Data were analyzed after collecting sufficient 
number of samples. According to the demographic data, 
IGF-I association with age was also investigated. 
The mean urinary IGF-I level in each group was 
determined. Mann-Whitney, Kruskal-Wallis and Chi-
square tests were used to compare the correlation 
between urinary IGF-I levels and CVMSs.  Statistical 
significance was defined at P<0.05. 
 
 
Results 
In this study, the total number of participants was 50 
patients of which 19 (38%) and 31(62%) patients were 
male and female, respectively. The mean age of 8-18-
year-old participants in the present study was 
12.96±3.82. Distribution of patients in the five CVMSs 
is shown in table 1. There was no significant difference 
in the distribution of genders among these groups 
(p=0.106). 
 
Table 1. CVMSs based on gender. 
 Cervical vertebral maturational stages 
2 
N(%) 
3 
N(%) 
4 
N(%) 
5 
N(%) 
6 
N(%) 
Male 5(26.3) 6(31.6) 5(26.3) 0(0) 3(15.8) 
Female 5(16.1) 5(16.1) 6(19.4) 9(29) 6(19.4) 
Total 10(20) 11(22) 11(22) 9(18) 9(18) 
  
Regarding the absence of normal distribution of data 
in these two groups, the nonparametric test was used to 
compare IGF-I in both males and females. The results of 
the current study suggested that the IGF-I had no 
significant difference between men (0.030.04) and 
women (0.080.011) (Z=-0.688, p=0.492). The mean 
and standard deviation of IGF-I values in different 
CVM groups are illustrated in table 2. 
Regarding the absence of normal distribution of 
data, non-parametric test was used to compare IGF-I in 
different CVM groups. Kruskal-Wallis test was applied 
to compare IGF-I among CVMSs. There was a 
statistically significant difference only between group 
CVMS3 and other groups (p=0.0001). 
 
Table 2. Mean and standard deviation of IGF-I 
levels based on the CVMSs 
Cervical vertebral 
maturational stages 
Number Mean SD 
2 10 0.0000 0.00000 
3 11 0.2727 0.54789 
4 11 0.0182 0.04045 
5 9 0.0000 0.00000 
6 9 0.0000 0.00000 
TOTAL 50 0.0640 0.27237 
 
Discussion 
In the present study, the mean age of the 8-18-year-
old participants was 12.96 ± 3.82. There was no 
statistical difference in gender distribution among CVM 
groups. In this study, urine samples of male and female 
were used, because the use of either of these alone 
might lead to bias in the results since some of previous 
studies reported different levels of IGF-I between two 
genders. 
[18]
 However, in the current study the mean 
IGF-1 level in male and female was not statistically 
different. This difference in result may be due to culture 
and ethnicity affecting puberty in both genders. 
Yamamoto et al. evaluated various concentrations of 
IGF-I at different hours of the day, and reported higher 
levels in morning samples. They also demonstrated a 
positive correlation of IGF-1 accumulated in 24 hours 
with IGF-I morning urine. Therefore, we also collected 
urine samples in the morning. 
[19]
 Ryan et al. measured 
the amount of human salivary IGF-1, in which a low 
level of IGF-1 was found; hence, the accurate 
measurements were not possible. Furthermore, 
collecting salivary IGF-I is hard and there is a potential 
for contamination with saliva and blood fluid. 
Collecting and storing urine than saliva samples are 
relatively easier for the former is not technique-
sensitive. 
[16]
 
Masoud et al. demonstrated the association between 
IGF-I and CVM in 83 patients (44 women, 39 men) 
aged 5-22 years old. The result of their study was 
similar to our findings. The highest levels of IGF-I were 
found in stage 3, followed by stage 4. 
[20]
 This is due to 
accelerated growth rate of children in stage 3 as the 
preparing stage for peak growth spurt. 
Hizuka et al. collected 8 randomized urine samples 
for IGF-I from 8 normal individuals, 10 patients with 
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acromegaly and 9 patients with hypopituitarism as well 
as observed that IGF-1 reflected the state of growth 
hormone. 
[21]
 
Ratcliff et al. have evaluated the age-related IGF-I 
and found that the highest levels of hormone is secreted 
in stage 3. 
[22]
 Nevertheless, Hall et al. stated this peak 
in stage 4. 
[23]
 The result of the latter study was different 
from our findings. Quattrin et al. examined the level of 
secreted IGF-I in healthy and unhealthy children in 
terms of growth, and expressed that the secretion of this 
hormone was much higher at puberty than pre-puberty 
period. 
[24]
 Skeletal response to growth changes can be 
increased at stages 3 and 4. 
[25]
 Additionally, the highest 
growth rates of height and mandible have been 
represented in stages 3 and 4 of the CVM. 
[26]
 The 
maximum changes in ramus length and body length as 
well as the largest effects on condylion are also seen in 
stages 3 and 4. Besides, stages 3 and 4 exhibit the 
largest anterior rotation of gonial angle. Based on the 
findings of Gu et al. the peak mandibular growth occurs 
during the interval between stages 3-4. Forward rotation 
of the mandible is associated with higher mandibular 
growth posteriorly as compared to anteriorly. 
[27]
 
The results of the ongoing study are the same as 
most of the previous studies. The peak urinary IGF-I 
level in men and women was measured in stages 3 and 
4, representing the peak growth spurt. However, at other 
CVMSs, significant amounts of IGF-I could not be 
found in all samples, possibly because of low urinary 
levels of the hormone and difficulty in detecting it or 
due to possible laboratory errors. Urinary IGF-I levels 
were much lower than serum IGF-I levels. Yokoya et al. 
measured urinary IGF-I levels using immunoassay and 
found that it was about 1% of serum levels.
 [28]
 Thus, 
further studies with more precise kit may help to 
determine the urinary IGF-I level changes during 
puberty in orthodontic patients. 
 
 
Conclusion 
Based on the current study, it could be concluded 
that the peak level of urinary IGF-I coincided with 
CVMS 3 at growth spurt so that both of them 
represented peak growth in children. Therefore, the 
urinary IGF-1 may be considered as a promising tool for 
evaluating the growth peak without limitation of 
radiographic techniques in the future. More studies with 
more precise kits and procedures on Iranian population 
are needed.  
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